The Use of Rifaximin in Patients With Cirrhosis-Reference-Cited by-同舟云学术

The Use of Rifaximin in Patients With Cirrhosis

Published:2021-06-07 Issue:3 Volume:74 Page:1660-1673
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Caraceni Paolo¹^ORCID,Vargas Victor²,Solà Elsa³,Alessandria Carlo⁴,Wit Koos⁵^ORCID,Trebicka Jonel⁶⁷^ORCID,Angeli Paolo⁸,Mookerjee Rajeshwar P.⁹,Durand François¹⁰,Pose Elisa³,Krag Aleksander¹¹¹²,Bajaj Jasmohan S.¹³^ORCID,Beuers Ulrich⁵,Ginès Pere³^ORCID,Juanola Adrià,Napoleone Laura,Carol Marta,Avitabile Emma,Thu Ann Ma,Cervera Marta,Pérez Martina,Belén Rubio‐Garcia Ana,Ardiaca Alicia,Vives Adriana,Pich Judit,Fabrellas Núria,Zaccherini Giacomo,Chiappa Maria Teresa,Jiménez César,Palacio Ester,Campion Daniela,Lanzillotti Tommaso,Piano Salvatore,Nicolao Gea,Uschner Frank,Graf_Dirmeier Sabine,Francoz Claire,Roux Olivier,Esnault Vanessa,Helder Jeltje,Aban Marites,Kazankov Konstantin,Korenjak Marko,Kamath Patrick,Abraldes Juan G.,Watson Hugh,

Affiliation:

1. University of Bologna University Hospital S. Orsola‐Malpighi di Bologna Bologna Italy

2. Hospital Vall d’Hebron Universitat Autònoma de Barcelona CIEREHD Barcelona Catalonia Spain

3. Hospital Clinic of Barcelona University of Barcelona IDIBAPS CIBEReHD Barcelona Catalonia Spain

4. Division of Gastroenterology and Hepatology Città della Salute e della Scienza Hospital University of Torino Turin Italy

5. Amsterdam University Medical Centers Amsterdam the Netherlands

6. Goethe‐University ‐ Frankfurt am Main Frankfurt am Main Germany

7. EF‐CLIF Barcelona Catalonia Spain

8. University Hospital of Padova Padova Italy

9. Royal Free Hospital University College London London United Kingdom

10. Hospital Beaujon APHP Paris France

11. Department of Gastroenterology and Hepatology Odense University Hospital Odense Denmark

12. Institute of Clinical Research University of Southern Denmark Odense Denmark

13. Virginia Commonwealth University Medical Center Richmond VA

Funder

Instituto de Salud Carlos III

H2020 Health

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31708

Reference76 articles.

1. TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS

2. Treatment of Hepatic Encephalopathy

3. Comparison of Lactulose and Neomycin in the Treatment of Chronic Portal-Systemic Encephalopathy

4. Rifaximin Treatment in Hepatic Encephalopathy

5. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases;Seminars in Immunology;2024-02

2. Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension;Hepatobiliary & Pancreatic Diseases International;2024-02

3. Rifaximin-α: A Promising Ally in the Battle Against Alcohol-Related Liver Disease;Journal of Clinical and Experimental Hepatology;2024-01

4. The Application of Rifaximin in Patients with End Stage Liver Disease;Advances in Clinical Medicine;2024

5. Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial;American Journal of Gastroenterology;2024-01-01